Cellipont Bioservices Announces Grand Opening of Its Purpose-built Cell Therapy Manufacturing Facility
THE WOODLANDS, Texas, March 7, 2024 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), proudly announces the grand opening of its purpose-built 76,000 sq.
- THE WOODLANDS, Texas, March 7, 2024 /PRNewswire/ -- Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), proudly announces the grand opening of its purpose-built 76,000 sq.
- This facility includes 7 clean rooms, QC labs, temperature-controlled storage, segregated shipping bays, warehouse, and administrative offices, marking a significant milestone in Cellipont's mission to advance cell therapy development and manufacturing, while serving patients worldwide.
- ...marking a significant milestone in Cellipont's mission to advance cell therapy development and manufacturing, while serving patients worldwide.
- "Cellipont's commitment to advancing cell therapy manufacturing is truly commendable," commented Ann Tanabe, CEO of BioHouston.